A 28-year-old male intravenous drug user presents with fever, a new cardiac murmur, and multiple septic emboli on imaging. Blood cultures grow Staphylococcus aureus. Which is the most common valve affected in S. aureus infective endocarditis?

Explanation

## Most Common Valve in S. aureus Endocarditis **Key Point:** The tricuspid valve is the most commonly affected valve in S. aureus infective endocarditis, particularly in intravenous drug users (IVDU). This is a classic association that appears frequently in NEET PG. ### Epidemiology and Pathophysiology #### Why Tricuspid Valve? 1. **Right-sided endocarditis in IVDU**: Intravenous drug users inject bacteria-laden material directly into peripheral veins, which drain to the right heart. Tricuspid valve is the first valve encountered. 2. **Lower-pressure system**: The right heart is a low-pressure system with slower blood flow, allowing bacteria to seed and proliferate more easily on the tricuspid valve. 3. **Mechanical factors**: The tricuspid valve has less turbulent flow compared to left-sided valves, paradoxically making it more susceptible to bacterial colonization in the setting of bacteremia. 4. **Virulence factors**: S. aureus produces adhesins (fibronectin-binding proteins) that promote adherence to valve endothelium. ### Valve Involvement in S. aureus Endocarditis | Valve | Frequency | Clinical Context | Prognosis | |-------|-----------|------------------|----------| | **Tricuspid** | **Most common (60–70% in IVDU)** | Right-sided endocarditis, IVDU, septic emboli to lungs | Better (lower mortality than left-sided) | | Mitral | Common in non-IVDU, prosthetic valves | Left-sided endocarditis, systemic emboli | Worse (higher mortality) | | Aortic | Common in non-IVDU, prosthetic valves | Left-sided endocarditis, acute regurgitation, heart failure | Worst (highest mortality) | | Pulmonary | Rare | Very unusual, only in severe cases | Rare | **High-Yield:** In **native valve endocarditis** caused by S. aureus: - **IVDU**: Tricuspid >> mitral > aortic - **Non-IVDU**: Mitral ≥ aortic >> tricuspid This distinction is crucial for exam questions. ### Clinical Presentation of Tricuspid Endocarditis - **Septic pulmonary emboli**: Infarcts, cavitation, pleural effusions (most characteristic finding). - **Fever and constitutional symptoms**: Prolonged fever is common. - **New or changing murmur**: Tricuspid regurgitation murmur (holosystolic, increases with inspiration — Carvallo sign). - **Peripheral stigmata**: Less common than in left-sided endocarditis (no splinter hemorrhages, Osler nodes). - **Lower mortality**: Right-sided endocarditis has better prognosis (~5–10% mortality) compared to left-sided (~20–40%). **Clinical Pearl:** A patient with fever, septic pulmonary emboli on CXR, and a new tricuspid regurgitation murmur in the setting of IVDU is pathognomonic for S. aureus tricuspid endocarditis until proven otherwise. **Mnemonic:** **TRIP** — Tricuspid (most common in IVDU), Right-sided, IVDU (intravenous drug users), Pulmonary emboli (septic). ### Diagnosis - **Blood cultures**: Multiple sets before antibiotics (gold standard). - **Echocardiography**: TEE > TTE for visualization of vegetations and complications. - **Modified Duke criteria**: Used for diagnosis of infective endocarditis. ### Management 1. **Empiric antibiotics**: Nafcillin or oxacillin (if MSSA) or vancomycin (if MRSA) + gentamicin for synergy. 2. **Duration**: 4–6 weeks depending on valve involvement and complications. 3. **Surgical intervention**: Indicated for large vegetations (>10 mm), recurrent emboli, prosthetic valve involvement, or hemodynamic instability. 4. **Addiction management**: Concurrent substance abuse counseling and rehabilitation. [cite:Harrison 21e Ch 298; Mandell, Douglas & Bennett's Principles and Practice of Infectious Diseases Ch 191]